BAM
GNMK

Bullseye Asset Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bullseye Asset Management’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-117,747
Closed -$1.72M – 109
2020
Q4 		$1.72M Sell
117,747
-1,782
-1% -$23.6K 0.64% 60
2020
Q3 		$1.7M Buy
119,529
+14,923
+14% +$228K 0.77% 51
2020
Q2 		$1.54M Buy
104,606
+25,645
+32% +$261K 0.82% 48
2020
Q1 		$325K Sell
78,961
-311
-0.4% -$1.46K 0.39% 63
2019
Q4 		$381K Buy
+79,272
New +$437K 0.37% 62

Other funds holding GNMK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bullseye Asset Management's GNMK Position: Q1 2021 in Review

Bullseye Asset Management sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 117,747 shares — an estimated $1.72M sold.

Bullseye Asset Management first reported a position in GNMK in Q4 2019 and held it in 5 quarters. The position peaked at $1.72M in Q4 2020. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

  • Bullseye Asset Management reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
  • Bullseye Asset Management sold 117,747 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $1.72M.
  • Bullseye Asset Management first reported a position in GenMark Diagnostics, Inc in Q4 2019 and held it in 5 quarters.
  • Bullseye Asset Management's GenMark Diagnostics, Inc position peaked at $1.72M in Q4 2020.
  • 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on Bullseye Asset Management's 13F filing for Q1 2021, filed 13 May 2021.